SEC 13F Intelligence

Fayez Sarofim & Co / ABBV

Fayez Sarofim & Co’s Abbvie Inc Position

Does Fayez Sarofim & Co own Abbvie Inc (ABBV)? Yes — 2.76M shares worth $599M (+1.53% of its 13F portfolio) as of Q1 2026, up from 2.58M shares the prior filed quarter.

Position Value
$599M
Q1 2026
Shares
2.76M
% of Portfolio
+1.53%
Quarters Held
30
currently held

Position History ABBV

Reported value by quarter
Q4 ’18: $317MQ4 ’18Q1 ’19: $274MQ2 ’19: $244MQ3 ’19: $249MQ4 ’19: $283MQ4 ’19Q1 ’20: $232MQ2 ’20: $337MQ3 ’20: $279MQ4 ’20: $328MQ4 ’20Q1 ’21: $318MQ2 ’21: $271MQ3 ’21: $237MQ4 ’21: $299MQ4 ’21Q1 ’22: $359MQ2 ’22: $338MQ3 ’22: $296MQ4 ’22: $327MQ4 ’22Q1 ’23: $331MQ2 ’23: $257MQ3 ’23: $298MQ4 ’23: $337MQ4 ’23Q1 ’24: $351MQ2 ’24: $348MQ3 ’24: $405MQ4 ’24: $392MQ4 ’24Q1 ’25: $454MQ2 ’25: $402MQ3 ’25: $501MQ4 ’25: $590MQ4 ’25Q1 ’26: $599Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.76M$599M+1.53%
Q4 20252.58M$590M+1.42%
Q3 20252.16M$501M+1.16%
Q2 20252.17M$402M+0.97%
Q1 20252.17M$454M+1.13%
Q4 20242.21M$392M+0.95%
Q3 20242.05M$405M+1.03%
Q2 20242.03M$348M+0.94%
Q1 20241.93M$351M+1.04%
Q4 20231.93M$337M+1.03%
Q3 20232.00M$298M+1.01%
Q2 20231.91M$257M+0.90%
Q1 20232.07M$331M+1.16%
Q4 20222.02M$327M+1.21%
Q3 20222.20M$296M+1.17%
Q2 20222.21M$338M+1.23%
Q1 20222.22M$359M+1.14%
Q4 20212.21M$299M+0.90%
Q3 20212.19M$237M+0.78%
Q2 20212.41M$271M+0.91%
Q1 20212.94M$318M+1.17%
Q4 20203.06M$328M+1.26%
Q3 20203.18M$279M+1.19%
Q2 20203.43M$337M+1.55%
Q1 20203.05M$232M+1.43%
Q4 20193.19M$283M+1.36%
Q3 20193.29M$249M+1.28%
Q2 20193.35M$244M+1.26%
Q1 20193.40M$274M+1.45%
Q4 20183.44M$317M+1.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fayez Sarofim & Co’s full portfolio or all institutional holders of ABBV.